Article Information
History
- March 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jennifer A. Jenks1,
- Cody S. Nelson, PhD1,
- Hunter K. Roark1,
- Matt Goodwin1,
- Robert F. Pass, MD2,
- David I. Bernstein, MD3,
- Emmanuel B. Walter, MD1,
- Kathryn M. Edwards, MD4,
- Dai Wang, PhD5,
- Tong-Ming Fu, MD PhD6,
- Zhiqiang An, PhD6,
- Cliburn Chan, PhD1,† and
- Sallie R. Permar, MD PhD1,†,*
- 1Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
- 2Department of Pediatrics, University of Alabama Birmingham, Birmingham, AL
- 3Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH
- 4Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
- 5Merck & Co., Inc., Kenilworth, NJ, USA
- 6Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, USA
- ↵*Corresponding author: Sallie R. Permar sallie.permar{at}duke.edu
↵† Drs. Chan and Permar contributed equally.